Observational studyBMC cancer2018

Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study.

Peter Dall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.